By proceeding, you agree to our Terms of Use and Privacy Policy.
The Precision Medicine in Inflammatory Bowel Disease Summit aims to address the urgent need for personalized care for the 10 million people worldwide living with IBD. The current one-size-fits-all approach to treatment is not effective, and precision medicine offers a solution through informed decision-making based on patient selection and clinical monitoring. This can lead to reduced costs, prevention of relapses, and long-term remission. Industry experts from pharma, biotech, and academia will gather to share their knowledge and benchmark novel markers and innovative technology such as RNA-sequencing, metabolomics, and proteomics. The Summit provides a unique opportunity for cross-indication collaboration to translate basic immunology into clinical response and develop biomarker strategies. The Precision Medicine in Inflammatory Bowel Disease Summit has been developed in collaboration with key thought leaders from AbbVie, Celsius Therapeutics, Crohn’s & Colitis Foundation, Janssen, Prometheus Bioscience, and others. Attendees will gain valuable insights to improve clinical trial efficacy and patient care for those suffering from IBD.
Explore biomarker tools to advance precision medicine in colitis and Crohn’s disease.
Learn about new signatures for subtyping IBD, uncovering novel therapeutic targets, and embracing artificial intelligence and non-invasive markers of IBD.
Experience insightful sessions and workshops to delve into the future of microbiome in IBD & how to achieve quality assurance when developing IBD markers.
Hear from top industry leaders from across pharma and biotech to improve your clinical trial efficacy and patient care for those suffering from IBD.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Karius sees a world where infectious disease is no longer a major threat to human health.
At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases.
PredictImmune develops pioneering tools for guiding personalised treatment options in immune-mediated diseases such as inflammatory bowel disease (IBD).
Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.